The European Commission grants final authorisation for isatuximab (Sarclisa®) for transplant eligible newly diagnosed myeloma patientsMPE25 July 2025
Register now to join the webinar ‘How do different countries make decisions on reimbursing new medicines?’Access, MPE6 March 2025
MPE member spotlight: Fundacja Carita´s European Forum of Haemato-Oncological PatientsMPE, News6 February 2025
Register for MPE´s European Young Myeloma Patients Group webinar on myeloma and physical fitnessMPE, Myeloma, News5 February 2025
MPE at ASH 2024: key research and expert insights on myelomaAL amyloidosis, CAR-T, Conferences, MPE, Myeloma16 December 2024
